AIM2 and Alzheimer disease: In the 5XFAD model of AD, deletion of AIM2 resulted in a decrease in Aβ deposition, but caused an elevation in the production of the key inflammatory cytokines IL-6 and IL-18, further supporting a negative regulatory role for AIM2 in neuroinflammation (219).